Evidence map›Paper›PMID 32377863›Full record

SynthesisReviews in endocrine & metabolic disorders2020

Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis.

Harriet M Pearsey, Joseph Henson, Jack A Sargeant, Melanie J Davies, Kamlesh Khunti, Toru Suzuki, Kelly A Bowden-Davies, Daniel J Cuthbertson, Thomas E Yates

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Reviews in endocrine & metabolic disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Harriet M PearseyDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK. hmp23@leicester.ac.uk.
Joseph HensonDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK.
Jack A SargeantDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK.
Melanie J DaviesDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK.
Kamlesh KhuntiDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK.
Toru SuzukiNIHR Leicester Biomedical Research Centre, Leicester, UK.
Kelly A Bowden-DaviesSchool of Biomedical Sciences, Newcastle University, Newcastle, UK.
Daniel J CuthbertsonClinical Sciences Centre, Aintree University Hospitals NHS Foundation Trust, Liverpool, UK.
Thomas E YatesDiabetes Research Centre, Leicester General Hospital, Gwendolen Road, Leicester, LE5 4PW, UK.
Leicester General Hospital · GBNIHR Leicester Biomedical Research Centre · GBGlenfield Hospital · GBNewcastle University · GBNIHR Clinical Research Network · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To systematically review the current literature investigating associations between zinc-alpha2-glycoprotein (ZAG) and dysglycaemia (including type 2 diabetes (T2DM), poly-cystic-ovary syndrome (PCOS), pre-diabetes or insulin resistance). This included relationships between ZAG and continuous measures of insulin and glucose. Additionally, we performed a meta-analysis to estimate the extent that ZAG differs between individuals with or without dysglycaemia; whilst examining the potential influence of adiposity. A systematic search was performed on four databases for studies on circulating ZAG concentrations in adult human populations, comparing healthy controls to individuals with dysglycaemia. Key characteristics, including the mean ZAG concentrations (mg∙L

Indexed as

Insulin ResistanceAdipokinesDiabetes Mellitus, Type 2FemaleHumansOverweightPolycystic Ovary SyndromePrediabetic StateZn-Alpha-2-GlycoproteinAdipokinesAZGP1 protein, humanZn-Alpha-2-GlycoproteinAlpha-2-glycoprotein, zincAZGP1DysglycaemiaHyperglycaemiaInsulin resistance

Identifiers

PMID32377863
PMCPMC7557496
OpenAlexW3023406048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.